NAMS
NewAmsterdam Pharma Company N.V.
24.30$
+2.1%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 5.41 | 0.17 | 0.48 | 0.20 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | 0.00 | 5.41 | 0.17 | 0.48 | 0.20 | |
| 0.28 | 1.63 | 4.57 | 1.94 | 1.60 | 1.24 | |
| 0.09 | 0.26 | 1.03 | 0.46 | 0.75 | 0.93 | |
| 0.37 | 1.97 | 5.60 | 2.40 | 2.35 | 2.17 | |
| -0.37 | -1.97 | -0.19 | -2.23 | -1.87 | -1.97 | |
| 0.02 | 0.02 | 0.02 | 0.08 | 0.00 | – | |
| -0.40 | -2.35 | -1.19 | -2.15 | -2.56 | -1.78 | |
| 0.02 | 0.01 | 3.73 | 0.00 | 0.00 | – | |
| -0.40 | -2.35 | -1.19 | -2.15 | -2.56 | -1.78 | |
| -0.37 | -2.33 | -1.18 | -2.15 | -2.56 | -2.12 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.